Click any tag below to further narrow down your results
Links
A16z Crypto argues the industry has made substantial regulatory progress over the past three years despite the Clarity bill stalling in the Senate, pointing to concrete wins like federal stablecoin law and agency guidance that have fundamentally shifted what's possible for crypto companies in the U.S.
- The U.S. passed GENIUS (federal stablecoin law), Congress overturned the IRS DeFi broker rule, the SEC rescinded SAB 121 accounting rules, and FinCEN withdrew the Unhosted Wallet Rule—removing major compliance barriers that previously forced companies to hire lawyers or leave the country.
- The SEC and CFTC have issued frameworks and guidance on token offerings, crypto asset safeguarding, centralized exchange regulation, and how existing law applies to crypto, answering questions the industry spent years trying to get Washington to address.
- Three years ago, founders faced genuine uncertainty about whether they could legally operate crypto companies in America; now the regulatory environment has shifted enough that staying in the U.S. is viable, even though durable legislation would provide longer-term certainty than agency guidance alone.
A new ICML paper argues that shifting fair machine learning toward causal reasoning actually harms policy objectives like diversity and equity, contrary to what researchers expected. The authors show that causal methods can produce worse outcomes than simpler approaches like removing sensitive features entirely.
- Causal fairness frameworks, despite seeming like improvements over traditional methods, can actively damage diversity and equity efforts in practice
- Removing sensitive attributes (the traditional "blinding" approach) sometimes outperforms causal reasoning for achieving policy goals
- The counterintuitive finding challenges the current direction of fair ML research, which has largely embraced causal thinking as more rigorous and principled
Hospital leaders are organizing a lobbying effort to delay or reverse nearly $1 trillion in Medicaid funding cuts over the next decade that were included in Trump's tax cut bill. The industry is exploring strategies to mitigate the damage to their operations and funding.
- Congress passed a law cutting nearly $1 trillion from Medicaid over 10 years as part of the Trump tax cut bill
- Hospital leaders are actively building plans to delay, roll back, or reduce the impact of these cuts
- The hospital industry is mobilizing its lobbying resources in Washington to fight the spending reductions
Trump issued an executive order directing federal agencies to call artificial intelligence "super intelligence" or "SI," claiming the word "artificial" makes it sound fake. The rebrand has minimal public support and confuses existing tech terminology, with experts doubting it will stick.
- Trump announced the rebrand at the UN on September 22 and signed an executive order on September 29 requiring all executive branch agencies to use "super intelligence" in official documents and communications, though he can't force private companies or foreign governments to follow suit.
- "Superintelligence" already has a specific meaning in AI research — it refers to hypothetical AI systems smarter than humans in all ways — making Trump's use of "super intelligence" misleading and confusing to the field.
- A YouGov poll found only 9 percent of the public supports the new name versus 53 percent who prefer "artificial intelligence," and multiple AI experts said the term won't catch on because it exaggerates current AI capabilities.
The article examines whether AI company leaders like Dario Amodei are engaging in regulatory capture or actually believe their policy positions. The author argues the evidence points to genuine conviction rather than self-interested industry manipulation.
- Regulatory capture is a slow process of erosion happening behind closed doors—companies lobby Congress, hire former regulators, and gradually shift agencies from confrontation to accommodation, using the ICC's railroad regulation as the classic example.
- Amodei's support for AI regulation would reduce his company's profits, which contradicts the self-interest motive central to regulatory capture theory—if he were capturing regulators, he'd push for deregulation instead.
- The simpler explanation (Occam's razor) is that Amodei actually believes what he's saying about AI safety and regulation, rather than engaging in the complex, hidden machinations that real regulatory capture requires.
Bill Gates argues that governments around the world are lagging badly in understanding and adopting artificial intelligence. The piece is a short Reuters report on his comments, with little beyond the headline and topic links in the scraped text to go on.
- Gates says governments worldwide are significantly behind the pace of AI development.
- The article is framed around a reputational angle, suggesting public institutions face credibility risk if they fall further behind.
- The scraped content is thin, so the specific examples and figures Gates cited aren't available here.
This is a virtual panel discussion about whether biosimilars—cheaper copies of expensive biologic drugs—have finally gained enough market traction to meaningfully lower drug costs. The speakers explore what's working, what's broken in the system, and what comes next as more blockbuster drugs face biosimilar competition.
- The first wave of biosimilars has launched, with more major drugs facing lower-cost competition soon
- The FDA has been removing regulatory barriers to speed biosimilar approvals in an effort to reduce drug spending
- Policy shifts and structural problems in the healthcare system could derail the cost-savings momentum biosimilars have built
This post announces the top three winners from a 600+ submission essay contest on major AI challenges. Jassi Pannu outlines a state-scale plan to end airborne pathogens, Ege Erdil advises growth-focused policies for countries outside the AI supply chain, and Michael Li compares AI labs’ economics to Hong Kong’s MTR model. Each full essay follows the brief winner descriptions.
- Far-UVC lighting infrastructure could cut seasonal flu mortality 60% and add $1T+ to global GDP for a $40-60B/10-year investment, while also blunting engineered pandemic risk.
- Erdil argues countries outside the AI supply chain should pursue standard growth policies (property rights, low capital taxes, light regulation) rather than geopolitical maneuvering to stay economically relevant.
- Li compares AI labs to Hong Kong's MTR, suggesting labs could offset massive compute costs by owning complementary "adjacent" assets rather than relying solely on core product revenue.
Anthropic told the Senate that Alibaba used about 25,000 fake accounts to run 28.8 million prompts against its Claude models between April 22 and June 5, calling it the largest known distillation attack on the company. At the same time, Anthropic faces a U.S. export control order suspending foreign access to its newest Claude models and is meeting with the Trump administration to resolve the dispute.
- Anthropic accused Alibaba of running roughly 25,000 fake accounts to send 28.8 million prompts to Claude between April 22 and June 5, calling it the largest known distillation attack on its models.
- Anthropic is simultaneously fighting a Commerce Department order forcing it to cut off foreign nationals, including its own non-U.S. staff, from its newest Claude models (Fable 5 and Mythos 5), citing unspecified national security concerns.
- Anthropic is lobbying Congress and the White House for industry-wide cooperation with cloud providers to detect and block distillation attacks, while also negotiating directly with the Trump administration to lift the export suspension.
Anthropic disabled Mythos 5 and Fable 5 after a US Commerce Department export-control order barred their use abroad. The administration asked for a pause amid reports of a narrow jailbreak letting Fable 5 analyze code for vulnerabilities. Anthropic says the issue produced only minor findings and that other models, like GPT-5.5, have similar capabilities.
- Anthropic disabled Mythos 5 and Fable 5 days after launch due to a Commerce Department export-control order barring their use outside the US.
- The trigger was a narrow jailbreak letting Fable 5 give cybersecurity/chemistry/biology advice on a specific codebase, but it only surfaced minor vulnerabilities.
- Anthropic claims other models like GPT-5.5 have similar capabilities, suggesting the singling-out of Fable 5 is inconsistent.
- The article's own account is internally contradictory: it names the Commerce Department order as Trump-administration action but then attributes the pause to "the Biden administration."
The article discusses a new initiative aimed at eliminating harmful microplastics from the environment. It highlights efforts to develop innovative solutions, including biosensors, to monitor and address this issue effectively.
- ARPA-H launched a program (STOMP) specifically targeting toxic microplastics, aiming to detect, monitor, and eliminate them from the environment
- The initiative will fund biosensor technology to enable fast, accurate detection of microplastics
- It brings together materials scientists, environmental health experts, and engineers, with funding aimed at projects with real-world deployment potential
- Goal is to generate actionable data that can shape regulatory and public health policy around microplastic contamination
Wyoming has officially launched the Frontier Stable Token (FRNT), the first blockchain-based asset backed by a U.S. state, utilizing the Solana blockchain. This state-issued stablecoin aims to provide public accountability and is designed to offer low-cost, efficient transactions while being backed by U.S. dollar reserves and short-duration U.S. Treasuries.
- Wyoming's Frontier Stable Token (FRNT) is the first state-backed stablecoin issued by a U.S. state, launched on Solana
- It's backed by U.S. dollar reserves and short-duration U.S. Treasuries, aiming for public accountability
- Designed to offer low-cost, efficient transactions